J&J’s Tecvayli/Darzalex Faspro Wins FDA Approval For Second-Line Myeloma

 
• By Alaric DeArment
  
Multiple Myeloma
J&J's combination of Tecvayli and Darzalex Faspro won FDA approval for second-line and later multiple myeloma (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip